About Amita Sharma, MD
Clinical Interests:
- Chronic kidney disease
- Genetic disorders affecting the regulation of mineral ion ho
- Glomerular disease
- Hypertension
- Kidney stone disease
- Nephrology
- Pediatric hypertension
- Pediatric nephrology
- Transplantation
Treats:
- Pediatrics
Languages:
- Hindi, Punjabi
Locations
Mass General for Children: Pediatric Nephrology and Kidney Transplant Program
55 Fruit St.
Boston, MA 02114
Phone: 617-726-2908
Mass General Brigham Healthcare Center
102-104 Endicott St.
Danvers, MA 01923
Phone: 617-726-2908
Fax: 617-643-9141
Medical Education
- MD, Maulana Azad Medical College
- Residency, University of Miami Hosp. & Clinics
- Fellowship, University of Miami Hosp. & Clinics
American Board Certifications
- Pediatric Nephrology, American Board of Pediatrics
- Pediatrics, American Board of Pediatrics
Accepted Insurance Plans
- Aetna
- Beech Street
- Blue Cross Blue Shield
- Blue Cross Blue Shield Medicare
- Cigna
- Commonwealth Care Alliance
- Coventry
- Fallon Health
- Harvard Pilgrim Health Care
- Humana
- Maine Community Health Options
- Mass General Brigham Health Plan
- MassHealth
- Medicaid CT
- Medicaid ME
- Medicaid NH
- Medicaid RI
- Medicare
- Medicare ACO
- Multiplan
- Railroad Medicare
- Senior Whole Health
- TriCare
- Tufts Health Plan
- United Health Care
- Wellpoint
- WellSense
- WellSense NH
Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.
Research
My clinical interests and expertise are complement mediated renal disease,high risk transplant,parathyroid disorders, and kidney stones.
My contribution to genetic research has revealed molecular defect of different phosphate-wasting disorders. These efforts led to the identification of a novel GLUT2 mutations in a consanguineous family with extremely severe, longstanding hypophosphatemic rickets, but surprisingly without major changes in the regulation of blood sugar. I also participated in molecular genetic studies identifying novel NPT2c mutations leading to nephrocalcinosis, and novel potassium channel mutations causing Bartter syndrome.